Skip to content
Credit reportVerdict and grounds
Made on 19-11-2026 at 11:54
Reference CK-1001874396-20261119

Curepreventperform

ActivePrivate limited company1001.874.396Hollebeekstraat 16, 9880 Aalter
Physiotherapy (NACE 86951) · founded in 2023 · one director · accounts in the micro format

Sources: the KBO register on 19-11-2026; the National Bank, 2025 annual accounts filed on 10-08-2026; the Belgian Official Gazette, latest deed of 06-11-2023.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 24,214 micro companies in the human health sector (NACE 86) is below 0.1%.
Gross margin
€94,052
▼ 36.5% against 2024
Net result
€58,372
▼ 42.7% against 2024
Equity
€160,394
▲ 57.2% against 2024
Cash
€94,362
▲ 187.5% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. In 2025, Curepreventperform closed with a net profit of €58,372.Annual accounts 2025 page 2
  2. Equity stands at €160,394, or 87.4% of the balance sheet total of €183,468. That is more than 56% of the 21,370 companies in the human health sector (NACE 86).Annual accounts 2025 page 2
  3. The 2025 accounts reached the National Bank on 10-08-2026, 10 days after the term.National Bank, filing of 10-08-2026 page 4

Representation

Checked did not find the signing rule in the deeds it read.

Ownership

The accounts in the micro format list no shareholders. holds 100 shares.

Deed of 06-11-2023

Curepreventperform · 1001.874.396 · credit report of 19-11-2026Page 1 of 5
Curepreventperform1001.874.396 · report of 19-11-2026

Financial situation

Annual accounts 2024 to 2025, as filed with the National Bank

Gross margin and net resultin euro

2024148,100202594,0522024101,923202558,372
gross marginnet result

Equity and debtsin euro

20242025160,39423,074
equitydebts

Cashin euro

202432,827202594,362
on the balance sheet date
Financial year202413 months2025Trend
Results
Gross margin€148,100€94,052
Operating result€132,174€75,714
Net result€101,923€58,372
Balance sheet at the closing date
Equity€102,023€160,394
Debts€19,851€23,074
Debts due within one year€18,736€22,144
Cash€32,827€94,362
Balance sheet total€121,873€183,468
Ratios
Solvency83.7%87.4%
Liquidity2.375.36

Source: Annual accounts 2025, micro format, filed on 10-08-2026 (2026-00390089); Annual accounts 2024, micro format, filed on 24-06-2025 (2025-00168032).

The operating result of 2025 is 43% lower than in 2024.

Debts rose by €3,223 in 2025, of which €1,150 to suppliers.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

Curepreventperform states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €148,100 to €94,052.

Curepreventperform · 1001.874.396 · credit report of 19-11-2026Page 2 of 5
Curepreventperform1001.874.396 · report of 19-11-2026

Board, signature and ownership

Position on 19-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

Checked did not find the signing rule in the deeds it read.

Board

one director in office
Director (not named in the articles)appointed by deed of 06-11-2023
deed of 06-11-2023

Ownership and group

Shareholders

The accounts in the micro format list no shareholders. holds 100 shares.

Deed of 06-11-2023

Curepreventperform · 1001.874.396 · credit report of 19-11-2026Page 3 of 5
Curepreventperform1001.874.396 · report of 19-11-2026

Events and comparison

The last 24 months, newest first

Annual accounts 2025 filed, 10 days late.

NBB filing

Liquidity more than doubled. The current ratio rises from 2.37 to 5.36.

Financial

Equity above €150,000. With a profit in every financial year since 2024, equity grows to €160,394.

Financial

Annual accounts 2024 filed, 37 days before the deadline.

NBB filing

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Curepreventperform has now: micro, 2 to 5 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 95.7% were still trading, 2.5% had stopped another way and 1.8% had gone bankrupt.

still trading 95.7% stopped another way 2.5% bankrupt 1.8%

In 2025, Curepreventperform had a lower net result than 51% of the 21,355 companies in the human health sector (NACE 86).

Other findings

Peppol

Reachable for e-invoices since 20-06-2024, under 0208:1001874396.

Sanctions lists

Curepreventperform · 1001.874.396 · credit report of 19-11-2026Page 4 of 5
Curepreventperform1001.874.396 · report of 19-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units19-11-2026KBO 1001.874.396
National Bank of BelgiumAnnual accounts 2025, micro format10-08-20262026-00390089
National Bank of BelgiumAnnual accounts 2024, micro format24-06-20252025-00168032
Peppol DirectoryRegistration for e-invoices20-06-20240208:1001874396
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name16-11-2026no match
CheckedChecked score, bankruptcy probability, credit, comparable companies18-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 18-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

Curepreventperform · 1001.874.396 · credit report of 19-11-2026Page 5 of 5